All In Biotech

Drug Trial Radar · NCT01698164

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

Last checked: Nov 19, 2026Latest source record: Oct 2, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 1,200 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

1,200

Planned (sponsor's estimate)

Start

Dec 2008

Primary completion

Oct 2012

Sponsor

Lead sponsor
Peking Union Medical College HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 2, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 40 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to evaluate the benefit/risk of hormone replacement treatment among early menopausal women in China. This is a multi-centre, random, prospective study.

Conditions

  • Menopausal Syndrome
  • Cardiovascular Disease
  • Osteoporosis
  • Breast Cancer

Interventions

  • estradiol plus MPADrug

    Participants are given estradiol and synthetic progestin.

  • Ximingting TabletDrug

    Participants are given phytoestrogen.

  • estradiol plus progesteroneDrug

    Participants are given estradiol and natural progesterone.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in risk factors of cardiovascular disease at 12 months and 24 monthsTime frame: before the treatment, time point of taking the medicine for 1 year, time point of taking the medicine for 2 years
  2. Change from Baseline in risk factors of breast cancer at 12 months and 24 monthsTime frame: before the treatment, time point of taking the medicine for 1 year, time point of taking the medicien for 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • PUMCH

    Beijing, Beijing Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.